Yi Larson
2019 - Turning Point Therapeutics
In 2019, Yi Larson earned a total compensation of $12.6M as Former Executive Vice President and Chief Financial Officer at Turning Point Therapeutics.
Compensation breakdown
| Bonus | $360,757 |
|---|---|
| Non-Equity Incentive Plan | $283,500 |
| Option Awards | $11,715,012 |
| Salary | $158,523 |
| Other | $61,633 |
| Total | $12,579,425 |
Larson received $11.7M in option awards, accounting for 93% of the total pay in 2019.
Larson also received $360.8K in bonus, $283.5K in non-equity incentive plan, $158.5K in salary and $61.6K in other compensation.
Rankings
In 2019, Yi Larson's compensation ranked 486th out of 13,971 executives tracked by ExecPay. In other words, Larson earned more than 96.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 486 out of 13,971 | 97th |
Division Manufacturing | 180 out of 5,695 | 97th |
Major group Chemicals And Allied Products | 47 out of 2,194 | 98th |
Industry group Drugs | 39 out of 1,880 | 98th |
Industry Pharmaceutical Preparations | 32 out of 1,392 | 98th |
Source: SEC filing on April 29, 2022.
Larson's colleagues
We found three more compensation records of executives who worked with Yi Larson at Turning Point Therapeutics in 2019.